Here are the Form 4 insider transactions from Cencora, Inc. (COR) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow COR and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full COR filings page.
Cencora, Inc. (COR) EVP, Chief Data & Info Officer Pawan Verma converted 8,538 restricted stock units into 8,538 common shares on October 30, 2026; the grant was received for no consideration. To satisfy the tax withholding obligation incident to vesting, 4,254 shares were withheld at $330.84 per share. The reported restricted stock unit position following the transaction was 0.
Cencora, Inc. director Dennis M. Nally acquired 106 shares of common stock on October 30, 2026, in lieu of a $35,000 quarterly cash retainer under the Non-Employee Director Compensation Program. The reported per-share price was $330.84, and his reported direct holding after the transaction was 13,294 shares.
Cencora, Inc. director Lauren M. Tyler was granted 91 restricted stock units on October 30, 2026, in lieu of a $30,000 quarterly cash retainer under the Non-Employee Director Compensation Program. Receipt of the shares is deferred until cessation of service. Tyler's reported direct position following the award was 4,547 shares.
On October 30, 2026, Cencora, Inc. director Ellen Cooper was granted 91 restricted stock units in lieu of a $30,000 quarterly cash retainer under the Non-Employee Compensation Program. Receipt of the shares is deferred until cessation of service. The reported direct post-transaction position was 984 shares of common stock.
Cencora, Inc. SVP & Chief Accounting Officer Lazarus Krikorian reported a sale of 986 shares of common stock on November 2, 2026, at $330.96 per share. The sale was made under a Rule 10b5-1 plan. The transaction is described as a sale in the open market or a private transaction. Afterward, Krikorian directly held 14,197 shares.
Robert E. Sanchez, a director of Cencora, Inc. (COR), reported an acquisition of 275 shares of common stock in a restricted stock unit grant on October 1, 2026. The grant was received for no consideration and vests 100% on the first anniversary of the grant. His reported direct holdings after the grant were 275 shares. A separate entry lists 197 shares held in a revocable trust; Sanchez disclaims beneficial ownership except to the extent of his pecuniary interest in those shares.
Cencora, Inc. (COR) SVP & Chief Accounting Officer Lazarus Krikorian sold 986 shares of common stock on October 1, 2026, at $303.18 per share. The sale was reported under a Rule 10b5-1 trading plan. Krikorian directly held 15,183 shares after the transaction. The transaction was a direct sale of non-derivative common stock.
Cencora, Inc. (COR) director Lon R. Greenberg reported selling 1,280 shares of common stock on September 16, 2026 at $321.30 per share, for proceeds of about $411,264. After this open-market sale, he directly holds 17,128 shares of Cencora common stock. No Rule 10b5-1 trading plan is reported.
Cencora, Inc. (COR) reported that SVP & Chief Accounting Officer Lazarus Krikorian sold 985 shares of common stock on September 1, 2026 in an open market or private transaction at $325.97 per share. After this sale, he held 16,169 shares directly. The sale was effected under a Rule 10b5-1 trading plan adopted on June 3, 2026.
Cencora, Inc. (COR) reported that Executive Vice President Elizabeth S. Campbell sold 11,300.471 shares of common stock on 2026-08-24 in an open market or private transaction. The weighted average sale price was $324.116 per share, based on multiple trades between $324.06 and $324.37. After this transaction, Campbell directly holds 19,455.085 shares of Cencora common stock. The Rule 10b5-1 checkbox was not marked as being pursuant to a trading plan.
NALLY DENNIS M reported acquisition or exercise transactions in this Form 4 filing.
Cencora, Inc. reported that director Dennis M. Nally received a grant of 113 shares of common stock on July 31, 2026 at $311.34 per share, issued in lieu of a $35,000 quarterly cash retainer under the Non-Employee Director Compensation Program. After this award, he directly holds 13,188 shares.
Cooper Ellen reported acquisition or exercise transactions in this Form 4 filing.
Cencora director Ellen Cooper received a grant of 97 restricted stock units on July 31, 2026, in lieu of a $30,000 quarterly cash retainer under the Non-Employee Director Compensation Program. The award equates to $311.34 per share, bringing her direct holdings to 893 shares, with receipt deferred until she leaves the board.
Tyler Lauren M reported acquisition or exercise transactions in this Form 4 filing.
Cencora, Inc. reported that director Lauren M Tyler received a grant of 97 restricted stock units representing common stock on 2026-07-31 at a reference price of $311.34 per share. The award was granted in lieu of a $30,000 quarterly cash retainer under the Non-Employee Director Compensation Program, with receipt of shares deferred until cessation of service. Following the grant, Tyler directly holds 4,456 shares of common stock.
Cencora, Inc. Executive Vice President Silvana Battaglia acquired 58.2040 shares of common stock on 2026-06-30 at $240.5330 per share through the company’s Employee Stock Purchase Plan, as described under Rule 16b-3(c) and 16b-3(d). Following this compensation-related acquisition, she directly holds 23,624.0120 common shares.
Cencora, Inc. Executive Vice President Elizabeth S. Campbell acquired additional common stock through the company’s Employee Stock Purchase Plan. She obtained 49.889 shares of common stock at a price of $240.533 per share in this routine, compensation-related transaction. Following the purchase, she directly holds 30,755.556 shares of Cencora common stock.
Boratto Eva C reported acquisition or exercise transactions in this Form 4 filing.
Cencora, Inc. reported that Chief Financial Officer Eva C. Boratto received a grant of 21,304 Restricted Stock Units. These RSUs were granted for no cash consideration and will vest in three equal annual installments on June 29, 2027, June 29, 2028, and June 29, 2029. Following this award, she holds 21,304 RSUs directly.
Cencora, Inc. director Lauren M. Tyler reported an open-market purchase of 550 shares of Common Stock at $270.23 per share. After this buy, Tyler directly holds 4,359 Cencora shares, indicating a modest increase in personal ownership.
Cencora, Inc. director Dermot Mark Durcan reported an open-market purchase of company stock. On June 18, 2026, he bought 4,000 shares of Cencora common stock at $274.19 per share. After this transaction, he directly holds 31,767 common shares of the company.
Cencora, Inc. director Dermot Mark Durcan reported an open-market purchase of 4,000 shares of Common Stock on 2026-05-28 at an average price of $266.26 per share. Following this transaction, he directly owns 27,767 Cencora shares.
Tyler Lauren M reported acquisition or exercise transactions in this Form 4 filing.
Cencora, Inc. director Lauren M. Tyler received an equity award rather than making an open-market trade. On May 1, 2026, Tyler was granted 99 shares of Common Stock, reported at $304.00 per share, under the company’s Non-Employee Director Compensation Program.
The award represents restricted stock units granted in lieu of a $30,000 quarterly cash retainer, with actual receipt of the shares deferred until Tyler’s board service ends. After this grant, Tyler directly holds 3,809 shares of Cencora common stock, indicating this is a routine component of director compensation rather than a discretionary stock purchase or sale.
Cooper Ellen reported acquisition or exercise transactions in this Form 4 filing.
Cencora, Inc. director Ellen Cooper received an equity-based compensation award rather than cash. She was granted 99 shares of Common Stock on May 1, 2026, recorded at $304.00 per share, as a grant or award transaction.
According to the footnote, this is a grant of restricted stock units received in lieu of a $30,000 quarterly cash retainer under the company’s Non-Employee Director Compensation Program, with receipt of the shares deferred until she ceases board service. Following this award, she directly holds 796 shares of Cencora common stock.
NALLY DENNIS M reported acquisition or exercise transactions in this Form 4 filing.
Cencora, Inc. director Dennis M. Nally received an award of 116 shares of common stock on May 1, 2026. The shares were issued in lieu of a $35,000 quarterly cash retainer under the company’s Non-Employee Director Compensation Program.
Following this compensation grant, Nally directly holds 13,075 shares of Cencora common stock.
Krikorian Lazarus reported acquisition or exercise transactions in this Form 4 filing.
Cencora, Inc. reported that SVP & Chief Accounting Officer Lazarus Krikorian received a grant of 3,936 Restricted Stock Units on April 1, 2026. According to the filing, these Restricted Stock Units were received for no consideration and vest in full on April 1, 2028. Following this grant, Krikorian holds a total of 3,936 Restricted Stock Units directly.
Cencora, Inc. Executive Vice President Silvana Battaglia exercised restricted stock units into 8,415 shares of Common Stock on March 11, 2026. A portion of these shares, 3,673, was withheld at $350.30 per share to cover tax obligations related to the vesting. After these transactions, Battaglia directly owns 23,565.808 Cencora common shares.
Cencora, Inc. Executive Vice President Elizabeth S. Campbell exercised restricted stock units into common shares and had shares withheld to cover taxes. She converted 12,623 restricted stock units into 12,623 shares of common stock at no cash exercise price, then 5,842 shares were withheld at $350.30 per share to satisfy tax obligations incident to the vesting. After these compensation‑related transactions, she holds 30,705.667 shares of common stock directly.
Cencora, Inc. Chief Financial Officer James F. Cleary exercised restricted stock units into 12,623 shares of common stock. On the same date, 5,409 shares of common stock valued at $350.30 per share were withheld to satisfy tax obligations related to the vesting. After these transactions, Cleary directly owned 160,357.3479 shares of Cencora common stock.
Cooper Ellen reported acquisition or exercise transactions in this Form 4 filing.
Cencora, Inc. disclosed that director Ellen Cooper received equity awards in the form of restricted stock units. On March 5, 2026, she was granted 557 units at a reference price of $359.28 per share, increasing her direct holdings to 697 common shares. On January 30, 2026, she also received two smaller grants of 69 and 66 units at $359.22 per share, bringing her holdings to 74 and then 140 shares after those awards. Footnotes state these restricted stock unit grants were received for no cash consideration, generally vest 100% on the first anniversary of the grant date, and delivery of the underlying shares is deferred until she ceases Board service. One January grant was received in lieu of a quarterly cash retainer under the company’s non-employee director compensation program.
Cencora, Inc. director Dennis M. Nally reported acquiring a total of 655 shares of common stock in two non‑open‑market grants. On March 5, 2026, he received 557 shares at a reference price of $359.28 per share, and on January 30, 2026 he received 98 shares at $359.22 per share.
According to the footnotes, some of these shares were issued in lieu of a $35,000 quarterly cash retainer under the company’s non‑employee director compensation program, and an annual restricted stock unit grant was received for no consideration that vests 100% on the first anniversary of the grant date. After these awards, he directly owns 12,959 common shares.
Cencora, Inc. director Lauren M. Tyler reported two equity awards of common stock-based units. On March 5, 2026, Tyler acquired 557 shares as restricted stock units granted in lieu of a $30,000 quarterly cash retainer, with receipt of shares deferred until service ends. On January 30, 2026, Tyler acquired an additional 84 shares as an annual restricted stock unit grant received for no cash consideration, which vests in full on the first anniversary of the grant date. Both holdings are reported as directly owned.
Baumann Werner reported acquisition or exercise transactions in this Form 4 filing.
Cencora, Inc. director Werner Baumann received an annual equity award in the form of restricted stock units covering 557 shares of common stock at a reference price of $359.28 per share. The units were received for no cash consideration and will vest 100% on the first anniversary of the grant date. Following this grant, Baumann directly holds 3,687 shares of Cencora common stock.
Cencora, Inc. director Frank Clyburn reported an equity award of common stock. He acquired 557 shares of common stock, described as a grant of restricted stock units, at a reference price of $359.28 per share. The award was received for no cash consideration and is scheduled to vest 100% on the first anniversary of the grant date. Following this grant, his directly held common stock position increased to 1,724 shares.
DURCAN DERMOT MARK reported acquisition or exercise transactions in this Form 4 filing.
Cencora, Inc. director Dermot Mark Durcan reported an award of 905 shares of common stock on March 5, 2026, valued at $359.28 per share. The grant was in the form of restricted stock units received for no cash consideration and will vest 100% on the first anniversary of the grant date. Following this award, Durcan directly holds 23,767 shares of Cencora common stock.
GREENBERG LON R reported acquisition or exercise transactions in this Form 4 filing.
Cencora, Inc. director Lon R. Greenberg reported an automatic equity award. He received an annual grant of 557 restricted stock units of common stock at no cash cost. The award vests 100% on the first anniversary of the grant date, with delivery of the shares deferred until 01/15/2029.
Cencora, Inc. director Kim Lorence H. reported an acquisition of 557 shares of common stock through an annual grant of restricted stock units received for no cash consideration. The award vests 100% on the first anniversary of the grant date, with receipt of shares deferred until 3/10/2029. Following this grant, the director directly holds 4,081 common shares.
Cencora, Inc. director Redonda Miller reported an acquisition of company stock through an equity award. On the reported date, Miller received 557 restricted stock units at a reference price of $359.28 per share, increasing direct holdings to 3,751 shares. The award was received for no cash consideration, vests 100% on the first anniversary of the grant date, and delivery of the underlying shares is deferred until January 6, 2031.
Ryerkerk Lori reported acquisition or exercise transactions in this Form 4 filing.
Cencora, Inc. director Lori Ryerkerk reported receiving an equity award of 557 shares of common stock in the form of restricted stock units. The units were granted for no cash consideration and will vest 100% on the first anniversary of the grant date.
Following this award, Ryerkerk’s directly held common stock equivalent position increased to 1,073 shares, reflecting her updated ownership after the grant and before any future vesting or settlement events.
Cencora, Inc. President & CEO Robert P. Mauch exercised and sold company stock in related moves. He exercised a non-qualified stock option for 3,762 shares on February 20, 2026 at an exercise price of $86.09 per share, receiving common stock. On the same day, he sold 3,762 common shares in an open-market transaction at an average price of $358.94 per share. Following these transactions, his directly held common stock position was 65,393 shares. The option had become exercisable in four equal installments on November 13, 2020, 2021, 2022, and 2023.
Cencora, Inc. President & CEO Robert P. Mauch reported an open-market sale of 1,333 shares of common stock on February 18, 2026. The shares were sold at a price of $359.46 per share. After this transaction, his reported direct holdings total 65,393 common shares.
Cencora, Inc. President & CEO Robert P. Mauch reported an option exercise and share sale. On January 20, 2026, he exercised a non-qualified stock option for 3,763 shares of Cencora common stock at an exercise price of $86.09 per share. On the same date, he sold 5,096 shares of common stock at a price of $354.73 per share. After these transactions, he directly owned 66,726 shares of Cencora common stock and held 3,762 stock options linked to common shares. The option referenced in the filing became exercisable in four equal installments from November 13, 2020 through November 13, 2023.
Cencora, Inc. Executive Vice President Silvana Battaglia reported acquiring company shares through an employee stock purchase program. On December 31, 2025, she acquired 27.344 shares of Cencora common stock at a price of $287.088 per share under the Employee Stock Purchase Plan, which is noted as exempt under Rule 16b-3(c) and Rule 16b-3(d). After this purchase, she beneficially owned 18,823.808 shares of common stock in direct ownership.
Cencora, Inc. Executive Vice President Elizabeth S. Campbell reported a small purchase of company common stock. On December 31, 2025, she acquired 33.526 shares of Cencora common stock at a price of $287.088 per share. The filing states this purchase was made through the company’s Employee Stock Purchase Plan under exemptions provided by Rule 16b-3(c) and Rule 16b-3(d). After this transaction, Campbell beneficially owned a total of 23,924.667 shares of Cencora common stock, held in direct ownership.
Cencora, Inc. reported an insider stock sale by an executive vice president on a Form 4. On 12/19/2025, the officer sold 1,677 shares of Cencora common stock at a price of $345 per share, coded as a sale transaction. After this trade, the reporting person beneficially owned 18,796.464 shares of common stock directly. The filing reflects a single non-derivative transaction, with no derivative securities reported.
Cencora, Inc. reported that one of its executive vice presidents, an officer of the company, sold shares of its common stock. On 12/19/2025, the officer disposed of 3,351 shares of Cencora common stock in an open market sale at a price of $342.1 per share. After this transaction, the officer directly beneficially owned 23,891.141 shares of Cencora common stock. This filing reflects a routine insider transaction reported on a Form 4 by a single reporting person.
Cencora, Inc. President & CEO Robert P. Mauch exercised 3,763 Non-qualified Stock Options at an exercise price of $86.09 per share on December 18, 2025, receiving the same number of common shares. On the same date he sold 5,096 common shares at $343.45 per share. After these transactions, he directly holds 68,059 common shares and 7,525 Non-qualified Stock Options expiring November 13, 2026, which were exercisable in four equal installments between November 13, 2020 and November 13, 2023.
Cencora, Inc. disclosed that its President & CEO and Director, Robert P. Mauch, made a bona-fide gift of company stock. On 12/17/2025, he transferred 3,000 shares of common stock, coded as a gift, at a reported price of $0 per share, to a charitable donor advised fund. After this transaction, he beneficially owns 66,392 shares of Cencora common stock in direct ownership. The filing is made by a single reporting person and reflects a charitable transfer rather than a market sale or purchase.
Cencora, Inc. disclosed that one of its senior officers reported a stock sale. The reporting person, identified in the signature block as Lazarus Krikorian, who serves as SVP & Chief Accounting Officer, filed a Form 4 as an individual reporting person.
On 12/17/2025, the officer sold 4,031 shares of Cencora common stock at a price of $343.235 per share, coded as a disposition transaction. After this sale, the officer directly beneficially owned 17,154 shares of Cencora common stock. The filing shows the ownership as direct, with no derivative securities reported in the derivative securities table.
Cencora, Inc. reported an insider equity transaction by its Chief Financial Officer, James F. Cleary. On 12/17/2025, he exercised a non-qualified stock option for 45,154 shares of common stock at an exercise price of $86.09 per share. This option, originally vesting in four annual installments beginning in 2020, is now fully exercised with 0 options remaining from that grant.
To cover tax withholding related to the option exercise, 26,952 shares of common stock were disposed of, as noted by the transaction code "F" and the explanation of responses. After these transactions, Cleary directly held 153,143.3479 shares of Cencora common stock.
Cencora, Inc. director Dennis M. Nally reported a charitable stock gift. On 12/17/2025, he made a bona fide gift of 1,173 shares of Cencora common stock, recorded at a price of $0 per share, to a charitable donor advised fund.
After this transaction, Nally beneficially owns 12,304 shares of Cencora common stock in direct ownership. The filing reflects a personal charitable transfer rather than an open-market sale.
Cencora, Inc. President & CEO and director Robert P. Mauch reported equity transactions dated 12/15/2025. He acquired 638 shares of common stock in a transaction coded “M” related to restricted stock units and then disposed of 638 shares in a transaction coded “F” at a price of $350.32 per share to cover FICA and associated income taxes on a 2025 restricted stock unit grant. The $350.32 price was the closing price of the company’s common stock on 12/15/2025 used to calculate this tax obligation. After these transactions, he beneficially owned 69,392 shares of common stock directly and 15,322 restricted stock units, including a 638-unit grant that vests in three equal installments on 11/12/2026, 11/12/2027 and 11/12/2028.
Cencora, Inc.'s chief financial officer reported equity compensation activity involving restricted stock units and related tax withholding. On 12/15/2025, 199 shares of common stock were acquired in connection with restricted stock units, and 199 shares were then withheld to satisfy FICA and associated income tax obligations on a 2025 restricted stock unit grant, using a share price of $350.32.
After these transactions, the officer directly held 134,941.3479 shares of common stock and 4,534 restricted stock units. The restricted stock units referenced in the filing vest in three equal installments on 11/12/2026, 11/12/2027 and 11/12/2028.